MedNet.nl: A Dutch population study shows that survival of patients with early relapsing/refractory (R/R) diffuse large cell B cell lymphoma (DLBCL) treated with second-line intensive therapy with or without autologous stem cell transplantation is poor.
22-06-2023 | Diffuse Large B-Cell Lymphoma | Congress News | News
EHA 2023